Meet the Mentee: John Ortiz
My name is John Ortiz and I’m currently a P2 pharmacy student. Over the summer I was an orientation leader…
Meet the Mentor: Christian Porcu
My name is Christian Porcu and I am a fifth-year Pharmacy Major with a Minor in Social Justice Theory. I…
LEADS Initiative
The LEADS Initiative is a pilot program developed in 2022 as a collaborative project between the Rho Chi Post Newsletter…
A Message from the Editor-in-Chief – Justin Budz
On behalf of the Rho Chi Post, we are excited to announce our Inaugural LEADS Initiative Edition of the Rho…
The 1980’s HIV and AIDS Epidemic
By: Christian Porcu, PharmD Candidate c/o 2024 and John Ortiz, PharmD Candidate c/o 2025 Human immunodeficiency virus (HIV) impairs immune…
Assessing the Efficacy of Cholecalciferol Versus Ergocalciferol for Vitamin D Repletion in Chronic Kidney Disease
By: Nancy Yousry, PharmD Candidate c/o 2024 Vitamin D is a multifaceted nutrient needed to maintain homeostasis and proper…
6th Year Perspective: APPE Rotations at the Westchester Medical Center Bundle
Featuring: Justin Budz, PharmD Candidate c/o 2023By: Isabelle Lim, PharmD Candidate c/o 2024 Justin Budz is a sixth-year pharmacy student…
Evaluating Treatments and Preventative Measuresfor Monkeypox
By: Sairah Sheikh, PharmD Candidate c/o 2024 As Coronavirus Disease 2019 (COVID-19) cases started to decrease in the United…
FDA Approval of Pemazyre® as a First-in-Class Treatment forMyeloid / Lymphoid Neoplasms with FGFR1 Rearrangement
By: Jennifer Galvet, PharmD Candidate c/o 2024 Fibroblast growth factor receptors (FGFRs) are a family of receptor tyrosine kinases…
Relyvrio: A New FDA-Approved Medication for Amyotrophic Lateral Sclerosis
By: Yu Jeng Lee, PharmD Candidate c/o 2023 Amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig’s disease,…